Abstract: In artificial intelligence, it is crucial for pattern recognition systems to process data with uncertain information, necessitating uncertainty reasoning approaches such as evidence theory.
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...